- Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial
- Biosimilar vs originator insulins: Systematic review and meta-analysis
- Long-term efficacy of safinamide on Parkinson's disease chronic pain
- Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence – A Danish nationwide study
- Long-term sustainability of glycaemic achievements with second-line anti-diabetic therapies in patients with type 2 diabetes: A real-world study
- Effects of levocetirizine and diphenhydramine on regional glucose metabolic changes and hemodynamic responses in the human prefrontal cortex during cognitive tasks
- Efficacy and safety of daily use of tadalafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial
- Efficacy and safety of artemisinin-based combination therapy for uncomplicated <em>Plasmodium falciparum</em> malaria in Sudan: A systematic review and meta-analysis
- No difference in effectiveness of 8 vs 12 weeks of ledipasvir and sofosbuvir for treatment of hepatitis C in black patients
- Preliminary clinical effect evaluation of resveratrol in adults with allergic rhinitis
- Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
- Pioglitazone improved insulin sensitivity and first phase insulin secretion among obese and lean people with diabetes: A multicenter clamp study
- Randomized phase II trial of autologous dendritic cell vaccines vs autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses
- Effects of insulin lispro mix 25 and insulin lispro mix 50 on postprandial glucose excursion in patients with type 2 diabetes: A prospective, open-label, randomized clinical trial
- Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: Results from a phase II trial
Feed Sources
